345 related articles for article (PubMed ID: 27067725)
1. Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biology.
Goel RK; Lukong KE
Cancer Metastasis Rev; 2016 Jun; 35(2):179-99. PubMed ID: 27067725
[TBL] [Abstract][Full Text] [Related]
2. The Rak/Frk tyrosine kinase associates with and internalizes the epidermal growth factor receptor.
Jin L; Craven RJ
Oncogene; 2014 Jan; 33(3):326-35. PubMed ID: 23318459
[TBL] [Abstract][Full Text] [Related]
3. The unique N-terminal region of SRMS regulates enzymatic activity and phosphorylation of its novel substrate docking protein 1.
Goel RK; Miah S; Black K; Kalra N; Dai C; Lukong KE
FEBS J; 2013 Sep; 280(18):4539-59. PubMed ID: 23822091
[TBL] [Abstract][Full Text] [Related]
4. The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion.
Je DW; O YM; Ji YG; Cho Y; Lee DH
Pancreas; 2014 Jul; 43(5):768-76. PubMed ID: 24763074
[TBL] [Abstract][Full Text] [Related]
5. RAKing in AKT: a tumor suppressor function for the intracellular tyrosine kinase FRK.
Brauer PM; Tyner AL
Cell Cycle; 2009 Sep; 8(17):2728-32. PubMed ID: 19652529
[TBL] [Abstract][Full Text] [Related]
6. Fyn-related kinase expression predicts favorable prognosis in patients with cervical cancer and suppresses malignant progression by regulating migration and invasion.
Zhang X; Li F; Zhu PL
Biomed Pharmacother; 2016 Dec; 84():270-276. PubMed ID: 27665472
[TBL] [Abstract][Full Text] [Related]
7. The tyrosine kinase FRK/RAK participates in cytokine-induced islet cell cytotoxicity.
Welsh M; Welsh C; Ekman M; Dixelius J; Hägerkvist R; Annerén C; Akerblom B; Mahboobi S; Chandrasekharan S; Liu ET
Biochem J; 2004 Aug; 382(Pt 1):261-8. PubMed ID: 15186217
[TBL] [Abstract][Full Text] [Related]
8. Repression of Fyn-related kinase in breast cancer cells is associated with promoter site-specific CpG methylation.
Bagu ET; Miah S; Dai C; Spriggs T; Ogunbolude Y; Beaton E; Sanders M; Goel RK; Bonham K; Lukong KE
Oncotarget; 2017 Feb; 8(7):11442-11459. PubMed ID: 28077797
[TBL] [Abstract][Full Text] [Related]
9. Protein-tyrosine Phosphatase and Kinase Specificity in Regulation of SRC and Breast Tumor Kinase.
Fan G; Aleem S; Yang M; Miller WT; Tonks NK
J Biol Chem; 2015 Jun; 290(26):15934-47. PubMed ID: 25897081
[TBL] [Abstract][Full Text] [Related]
10. A silent mutation made possible efficient production of active human Frk tyrosine kinase in Escherichia coli.
Yang X; Kinoshita T; Gouda M; Yokota K; Tada T
Biosci Biotechnol Biochem; 2010; 74(1):125-8. PubMed ID: 20057140
[TBL] [Abstract][Full Text] [Related]
11. Identification of a SRC-like tyrosine kinase gene, FRK, fused with ETV6 in a patient with acute myelogenous leukemia carrying a t(6;12)(q21;p13) translocation.
Hosoya N; Qiao Y; Hangaishi A; Wang L; Nannya Y; Sanada M; Kurokawa M; Chiba S; Hirai H; Ogawa S
Genes Chromosomes Cancer; 2005 Mar; 42(3):269-79. PubMed ID: 15611931
[TBL] [Abstract][Full Text] [Related]
12. In silico identification of oncogenic potential of fyn-related kinase in hepatocellular carcinoma.
Chen JS; Hung WS; Chan HH; Tsai SJ; Sun HS
Bioinformatics; 2013 Feb; 29(4):420-7. PubMed ID: 23267173
[TBL] [Abstract][Full Text] [Related]
13. Structure, Function, and Regulation of the SRMS Tyrosine Kinase.
McClendon CJ; Miller WT
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545875
[TBL] [Abstract][Full Text] [Related]
14. FRK suppresses the proliferation of human glioma cells by inhibiting cyclin D1 nuclear accumulation.
Hua L; Zhu M; Song X; Wang J; Fang Z; Zhang C; Shi Q; Zhan W; Wang L; Meng Q; Zhou X; Yu R
J Neurooncol; 2014 Aug; 119(1):49-58. PubMed ID: 24792491
[TBL] [Abstract][Full Text] [Related]
15. Characterization of mice deficient in the Src family nonreceptor tyrosine kinase Frk/rak.
Chandrasekharan S; Qiu TH; Alkharouf N; Brantley K; Mitchell JB; Liu ET
Mol Cell Biol; 2002 Jul; 22(14):5235-47. PubMed ID: 12077350
[TBL] [Abstract][Full Text] [Related]
16. Tracing the footprints of the breast cancer oncogene BRK - Past till present.
Goel RK; Lukong KE
Biochim Biophys Acta; 2015 Aug; 1856(1):39-54. PubMed ID: 25999240
[TBL] [Abstract][Full Text] [Related]
17. FRK controls migration and invasion of human glioma cells by regulating JNK/c-Jun signaling.
Zhou X; Hua L; Zhang W; Zhu M; Shi Q; Li F; Zhang L; Song C; Yu R
J Neurooncol; 2012 Oct; 110(1):9-19. PubMed ID: 22790444
[TBL] [Abstract][Full Text] [Related]
18. Src signaling in cancer invasion.
Guarino M
J Cell Physiol; 2010 Apr; 223(1):14-26. PubMed ID: 20049846
[TBL] [Abstract][Full Text] [Related]
19. Activation of STAT1 by the FRK tyrosine kinase is associated with human glioma growth.
Hua L; Wang G; Wang Z; Fu J; Fang Z; Zhuang T; Zhao L; Zong Z; Ye C; Liu H; Zhu Y; Yu R
J Neurooncol; 2019 May; 143(1):35-47. PubMed ID: 30993511
[TBL] [Abstract][Full Text] [Related]
20. FRK inhibits migration and invasion of human glioma cells by promoting N-cadherin/β-catenin complex formation.
Shi Q; Song X; Wang J; Gu J; Zhang W; Hu J; Zhou X; Yu R
J Mol Neurosci; 2015 Jan; 55(1):32-41. PubMed ID: 24969324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
